威高股份(01066.HK)附屬擬12.3億元收購Wego Healthcare Fund全部股權
格隆匯12月29日丨威高股份(01066.HK)公佈,於2020年12月29日,該附屬公司威海威高晟瑞健康科技有限公司就收購事項與威高集團公司訂立該協議,該附屬公司同意收購,而威高集團公司同意出售目標公司Wego Healthcare Fund Holding Corporation的全部已發行股本,收購事項的代價為人民幣12.3億元。
目標公司的主要資產為Rad Source的全部權益;及威海尚元壹期創業投資合夥企業(有限合夥)的19.8%權益。Rad Source創辦於1997年,旨在創造非伽瑪射線替代品,製造X射線輻照儀專利產品,設備位於世界各地的主要製藥實驗室、醫療機構及知名大學,總部位於美國喬治亞州布福德。
該附屬公司已授予威高集團公司該認購期權,以使威高集團公司或威高集團公司提名的實體可以代價人民幣3000萬元收購目標公司於該基金的19.8%權益。
公司董事會認為,收購事項將令集團可獲得血液X射線輻照技術領域的頂尖技術並向其現有血站客户銷售Rad Source產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.